Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Naloxone and Oxytocin

supplement:

Oxytocin

Research Papers that Mention the Interaction

We conclude that opioid receptor blockade with naloxone has an inhibitory effect on the neural pathways mediating the oxytocin response at orgasm.
The Journal of clinical endocrinology and metabolism  •  1990  |  View Paper
We discuss the potential benefit of concurrent administration of OT and naloxone (NAL) to robustly modulate social behavior.
Trends in Cognitive Sciences  •  2020  |  View Paper
In the presence of naloxone , plasma AVP and OT levels in response to nicotine were significantly higher than those in the control test.
Metabolism: clinical and experimental  •  1993  |  View Paper
Plasma OT concentrations rose significantly during ITT; the OT response was significantly reduced by the treatment with SRIH and increased in the presence of naloxone.
Metabolism: clinical and experimental  •  1989  |  View Paper
Antiallodynia induced by oxytocin (20 ng/site) was inhibited by prior intra-VLOC administration of atosiban (an oxytocin receptor antagonist, 100 ng/site) and naloxone (an opioid receptor antagonist, 500 ng/site).
Pharmacological reports : PR  •  2018  |  View Paper
OT coadministered with a μ-opioid receptor antagonist, naloxone , invoked a supralinear enhancement of prolonged and selective social attention, producing a stronger effect than the summed effects of each administered separately.
Proceedings of the National Academy of Sciences  •  2017  |  View Paper
Treatment with naloxone (an opioid antagonist) greatly enhanced the oxytocin response to IL‐1β in pregnancy, and finasteride did not enhance this effect, indicating that allopregnanolone and the endogenous opioid mechanisms do not act independently.
Journal of neuroendocrinology  •  2012  |  View Paper
The results showed that (1) the concentrations of OXT, L-Ek, M-Ek and β-Ep, not DynA(1-13) in …) in the PAG perfusion liquid were decreased by the OXT receptor antagonist; (3) the increased pain threshold induced by the OXT … naloxone , an opiate receptor … exogenous OXT administration.
Peptides  •  2011  |  View Paper
The opioid receptor antagonist, naloxone , increased oxytocin neuron post‐spike excitability in morphine‐dependent rats; this increase was greater for short interspike intervals (< 0.1 s).
The European journal of neuroscience  •  2005  |  View Paper
SummaryStudies performed in conscious female rats confirmed that iv injection of cholecystokinin octapeptide (CCK; 20µ/kg) … circulating concentration of oxytocin but not that of vasopressin, and confirmed that the stimulation of oxytocin release was markedly facilitated … iv administration of naloxone (1mg/kg), indicating attenuation of … release by endogenous opioids.
Experimental Brain Research  •  2005  |  View Paper
Show More